Allianz Asset Management GmbH
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 1535323
MUNICH, 2M
Position in DNA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,294,163
+$556,425 QoQ
Shares Held
700,516
+55.7% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allianz Asset Management GmbH holds $654,142,197 across 68 Biotechnology names. DNA ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
301,196 | $232,716,076 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
610,297 | $115,376,647 | |
| 3 | MRNA |
Moderna, Inc.
|
988,908 | $50,236,526 | |
| 4 | EXEL |
Exelixis, Inc.
|
954,551 | $40,940,690 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
400,020 | $22,597,128 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,441,683 | $20,846,736 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
47,662 | $15,769,925 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
706,664 | $15,730,340 |
All Filings in DNA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,294,163 | 700,516 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,737,738 | 449,788 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,801,692 | 192,160 | Shares | Defined | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||